Fund comparison · from official SEC filings

BIPIX vs CANC: how much do they overlap?

BIOTECHNOLOGY ULTRASECTOR PROFUND and Tema Oncology ETF
Holdings overlap
17%
of assets, by weight
Shared positions
33
of 147 / 57 holdings
BIPIX expense ratio
1.52%
net, per year
CANC expense ratio
0.75%
net, per year
Shared holdings
Company
BIPIX
CANC
R
RVMDREVOLUTION MEDICINES INC
1.17%
7.72%
C
COGTCOGENT BIOSCIENCES INC
0.80%
4.09%
I
IMNMIMMUNOME INC
0.64%
3.91%
C
CELCCELCUITY INC
0.84%
3.58%
?
Nuvalent Inc
0.81%
3.37%
A
ABBVABBVIE INC
0.75%
2.80%
E
EXELEXELIXIS INC
0.86%
2.77%
B
BBIOBRIDGEBIO PHARMA INC
0.80%
2.75%
C
CGONCG ONCOLOGY INC
0.81%
2.43%
I
IDYAIDEAYA BIOSCIENCES INC
0.45%
2.27%
A
AMGNAMGEN INC
0.74%
2.11%
R
RLAYRELAY THERAPEUTICS INC
0.35%
1.28%
H
HALOHALOZYME THERAPEUTICS INC
0.77%
1.23%
S
SMMTSUMMIT THERAPEUTICS INC
0.99%
1.20%
R
RCUSARCUS BIOSCIENCES INC
0.52%
1.20%
G
GILDGILEAD SCIENCES INC
0.72%
1.12%
E
ERASERASCA INC
0.48%
1.08%
A
ANABANAPTYSBIO INC
0.32%
0.99%
N
NTRANATERA INC
0.84%
0.54%
S
SNDXSYNDAX PHARMACEUTICALS INC
0.48%
0.80%
C
CRVSCORVUS PHARMACEUTICALS INC
0.31%
0.76%
R
REGNREGENERON PHARMACEUTICALS
0.74%
0.75%
A
AVBPARRIVENT BIOPHARMA INC
0.21%
0.73%
I
IOVAIOVANCE BIOTHERAPEUTICS INC
0.26%
0.65%
I
INBXINHIBRX BIOSCIENCES INC
0.36%
0.60%
Only in BIPIX
?
N/A
27.27%
A
AGPXXINVESCO GVT & AGNCY-INST
2.01%
1
1JKAPELLIS PHARMACEUTICALS INC
1.32%
T
TVTXTRAVERE THERAPEUTICS INC
1.15%
A
ARWRARROWHEAD PHARMACEUTICALS IN
1.02%
T
TWSTTWIST BIOSCIENCE CORP
1.00%
A
ALKSALKERMES PLC
0.98%
T
TGTXTG THERAPEUTICS INC
0.97%
M
MDGLMADRIGAL PHARMACEUTICALS INC
0.97%
B
BEAMBEAM THERAPEUTICS INC
0.94%
A
APGEAPOGEE THERAPEUTICS INC
0.89%
S
SRRKSCHOLAR ROCK HOLDING CORP
0.87%
P
PRAXPRAXIS PRECISION MEDICINES I
0.86%
M
MIRMMIRUM PHARMACEUTICALS INC
0.85%
U
UTHRUNITED THERAPEUTICS CORP
0.84%
C
CRSPCRISPR THERAPEUTICS AG
0.84%
K
KRYSKRYSTAL BIOTECH INC
0.83%
P
PTGXPROTAGONIST THERAPEUTICS INC
0.83%
N
NBIXNEUROCRINE BIOSCIENCES INC
0.82%
I
INCYINCYTE CORP
0.81%
C
CYTKCYTOKINETICS INC
0.81%
I
IONSIONIS PHARMACEUTICALS INC
0.80%
P
PCVXVAXCYTE INC
0.80%
K
KYMRKYMERA THERAPEUTICS INC
0.80%
B
BIIBBIOGEN INC
0.80%
Only in CANC
L
LLYELI LILLY & CO
4.82%
R
RHHBYROCHE HOLDINGS LTD-SPONS ADR
4.21%
N
NVSEFNOVARTIS AG-REG
4.03%
M
MRKMERCK & CO. INC.
3.57%
A
AZNASTRAZENECA PLC
3.53%
B
BMYBRISTOL-MYERS SQUIBB CO
3.30%
L
LEGNLEGEND BIOTECH CORP-ADR
2.99%
J
JNJJOHNSON & JOHNSON
2.54%
G
GMABGENMAB A/S -SP ADR
2.37%
Z
ZLABZAI LAB LTD-ADR
1.98%
O
ONCBEONE MEDICINES LTD-ADR
1.88%
Z
ZYMEZYMEWORKS INC
1.51%
E
ELVNENLIVEN THERAPEUTICS INC
1.31%
I
IMTXIMMATICS NV
1.12%
F
FXFXXFIRST AM TREAS OBLI-X
1.09%
N
NUVBNUVATION BIO INC
1.07%
U
URGNUROGEN PHARMA LTD
0.93%
G
GHGUARDANT HEALTH INC
0.81%
C
CHGCFCHUGAI PHARMACEUTICAL CO LTD
0.67%
I
IMCRIMMUNOCORE HOLDINGS PLC-ADR
0.51%
B
BBOTBRIDGEBIO ONCOLOGY THERAPEUT
0.47%
H
HCMHUTCHMED CHINA-ADR
0.44%
A
ARVNARVINAS INC
0.43%
A
ANLADLAI NORTYE LTD-ADR
0.30%
Hold BIPIX and CANC together? See your combined true holdings, overlap, and blended fees — free, no signup.
Unwrap your portfolio →
Data source: official SEC Form N-PORT filings from each fund. Fund holdings are disclosed quarterly and may reflect a 60-day reporting delay.
Informational and educational only — not investment advice.